Furthermore, according to the World Health Organization (WHO), cancer is a leading cause of death worldwide, and approximately 70% of deaths from cancer occur in low- and middle-income countries. By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths is expected to rise to 16.4 million. Thus, rise in prevalence of cancer is anticipated to drive the protein therapeutics market required for drug efficacy and safety.
The PEGylated protein therapeutics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 6.9% in the forecast period of 2021 to 2028. https://www.databridgemarketresearch.com/reports/global-pegylated-protein-therapeutics-market
Technavios market research analyst predicts the global protein therapeutics market to grow steadily at a CAGR of 8% during the forecast period. Increased demand for and use of monoclonal antibodies is expected to drive the growth of the protein therapeutics market as it accounts for more than half of the protein therapeutics market.
Global PEGylated protein therapeutics market is expected to grow at a growing CAGR of 8.7% in the forecast period of 2019-2026. Increase in strategic alliances between the pharmaceuticals companies and growing adoption of PEGylated protein therapeutics are the key factors that fueling the market growth.
Big Market Research “Protein Engineering Market by Technology” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.prnewswire.com/news-releases/protein-engineering-market-would-grow-at-157--cagr-amid-the-period-2015-2020-521544791.html Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design) , Product (Instrument, Services) , Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone) Global Forecast to 2020 - Developing Asian countries such as the China and India are lucrative markets for protein engineering, owing to increase in R&D investment by the biologics companies in these regions.
Major key players in the market are developing products with technically advanced features that are designed to produce high protein yield, maintaining a balance of speed and scalability, thereby enhancing its application in the drug development workflow. Some of the recent advanced product launched by the major players in the market include Gibco ExpiCHO expression system, launched in 2015 by ThermFisher Scientific Inc., that offers an increase yield of over 100-fold, thereby enabling upto 3g/L of protein yield; in comparison to its previous CHO system. Therefore, technically advanced products are a major factor driving the growth of the market during the forecast period.
The report on Protein Therapeutics by Infinium Global Research analyzes the the Protein Therapeutics Market over the period of 2018 to 2024. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Protein Therapeutics Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global markets of Protein Therapeutics.
Global Plasma Protein Therapeutic Market Size report includes all depth data like pre-market emphasis, forecast, market investment, industry advice, portfolio, finance, access, trade, market exploration, review and market effective strategies
The report on Metabolic Disorders Therapeutics Market by disease type (diabetes, obesity, hypercholesterolemia and lysosomal storage disease), product (metachromatic leukodystrophy, globoid leukodystrophy, hepatic encephalopathy and others) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Metabolic Disorders Therapeutics Market is projected to grow at a CAGR of 5.7% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
G-Protein Coupled Receptors (GPCRs) constitute a significant and diverse family of cell surface receptors, integral to various physiological processes. They play crucial roles in signal transduction pathways, mediating responses to diverse extracellular stimuli. With their involvement in numerous diseases, GPCRs have become primary targets for drug discovery and development endeavors. The global G-Protein Coupled Receptors market has seen substantial growth over the past decade, driven by advancements in drug discovery technologies, increasing research and development activities, and an expanding understanding of GPCR biology. The market encompasses a diverse range of therapeutic areas, including cardiovascular diseases, central nervous system disorders, metabolic disorders, oncology, and inflammation.
An extensive study of the product application and services conducted by subject matter experts assessing the market will help product owners to make a wise decision.
The growing investments in the synthetic biology sector and the increasing focus towards protein-based drug development are among the primary factors driving the protein engineering market. In line with this, the shifting preferences among consumers from non-protein drugs to protein therapeutics, owing to the associated positive clinical outcomes, are further propelling the market growth.
The protein expression market is expected to reach US$ 4,000.67 million in 2028 from US$ 2,221.73 million in 2021. The market is estimated to grow with a CAGR of 8.8% from 2021-2028.
Protein Ingredients Market size was valued at $ 35.69 Billion by 2020, and is anticipated to grow at a CAGR of 7.8% during the forecast period 2021-2026. The Protein Ingredients Market growth rate is attributed to the growing consumer demand for plant-based protein alternatives with growing consumer interest in foods that promote health and well-being are anticipated to bring new opportunities.
Protein Ingredients Market size was valued at $ 35.69 Billion by 2020, and is anticipated to grow at a CAGR of 7.8% during the forecast period 2021-2026.
Major players in the therapeutic proteins market are Abbott Laboratories, Amgen Inc., Baxter International Inc., Eli Lilly and Company..... @ @ https://bit.ly/30meAYf
Bone Morphogenetic Protein Market size is estimated to reach $3,700 million by 2026, growing at a CAGR of 6.1% over 2021-2026. Bone morphogenetic are also known as cytokines that helps to maintain and cartilage and ideal to insert specific cells and from a new bone.
Latest research report “Therapeutic Protein Market” published by TBRC provides Market Analysis Forecast, Size, Trends, Key Players, Segments and Growth. Read Full Report: http://bit.ly/2MJL7mr Request a Sample: http://bit.ly/2UiFhsQ
Exosome Diagnostic and Therapeutics Market: Germany, UK and France to Remain at the Forefront of Demand in the Western Europe Regional Market: Global Industry Analysis (2012 - 2016) and Opportunity Assessment (2017 - 2027)
Major players in the protein expression market are Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc, New England Biolabs.....@ @ https://bit.ly/3xdFeBv
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering GlaxoSmithKline Johnson & Johnson Merck Novartis Sanofi Eli Lilly F. Hoffmann-La Roche Dr. Reddy’s Laboratories
Batten disease is known to be a rare, inherent, and fatal nervous system disorder. It is the most general form of a group of disorders named as the neuronal ceroid lipofuscinoses (NCLs), which is known to be a class of life-limiting genetic neurogenerative diseases that are triggered because of abnormality of genes resulting in their inability to synthesize the essential protein. https://www.databridgemarketresearch.com/reports/global-batten-disease-treatment-market
The global protein expression market is expected to grow from $2.01 billion in 2020 to $2.13 billion in 2021 at a compound annual growth rate (CAGR) of 6%.
The Melanoma Therapeutics Market is expected to grow from USD 4.8 billion in 2020 to USD 9.1 billion by 2026 at a CAGR of over 11.3% during the forecast period. Skin cancer generally is of three types– squamous cell carcinoma, basal cell carcinoma, and melanoma. Melanoma is a type of skin cancer that forms from pigment-containing cells in the skin.
The major in the Therapeutic Proteins Market are Abbott Laboratories, Amgen Inc., Baxter International Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd...@ http://bit.ly/30meAYf
The global therapeutic proteins market is expected to grow from $90.53 billion in 2020 to $98.1 billion in 2021 at a compound annual growth rate (CAGR) of 8.4%.
Saudi Arabia Wellness Market Outlook to 2020 - Changing Demographics and Prevalence in Lifestyle Diseases will drive the Market" provides a comprehensive analysis of Wellness market in Saudi Arabia. The report covers various aspects such as market size of wellness market, market segmentation by wellness products & Services, fitness centers market size, spa/salon centers market size, personal care products market size, skin care market size
A recent report published by TheBusinessResearchCompany on Therapeutic Proteins Market provides in-depth analysis of segments and sub-segments in the global as well as regional. http://bit.ly/2t85BNq
A recent report published by TheBusinessResearchCompany on Protein Expression Market provides in-depth analysis of segments and sub-segments in the global as well as regional. http://bit.ly/2RjXoO0
Big Market Research adds a report “Pancreatic Cancer Therapeutics in Major Developed Markets- Size, Share, Trends, Forecast, Growth, Opportunities, Outlook " Get Complete Report @ http://www.bigmarketresearch.com/pancreatic-cancer-therapeutics-in-major-developed-to-2021-strong-late-stage-pipeline-holds-promise-for-increasingly-diverse-landscape-market The current late-stage drugs in development for PC address this clinical need; however, results so far have been limited in their efficacy, with none demonstrating clinically transformative efficacy or safety. As a result, the growth in PC prevalence as a result of a global aging population, increasing diabetes and obesity prevalence is expected to be the key driver of this market throughout the forecast period. Enquire about this report @ http://www.bigmarketresearch.com/report-enquiry/373733
Looking forward, the mRNA vaccines and therapeutics market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/mrna-vaccines-therapeutics-market
Get more details @ http://bit.ly/2jzEhBD Major industry companies for Protein A Resins Market include GE Healthcare, Repligen, GenScript, Tosoh Bioscience, Merck Millipore (EMD Millipore), Thermo Fisher Scientific, Novasep, Expedeon, Bio-Rad Laboratories, Danaher Corporation, Sigma-Aldrich, Purolite Life Sciences, Takara Bio, and Agarose Bead Technologies.
Major players in the protein expression market are Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., New England Biolabs and Promega Corporation.....@ https://bit.ly/3xdFeBv
The research study on Global Oral Proteins and Peptides Consumption 2016 Market Research Report by DecisionDatabases.com analyses the complete value chain of the Industry.
Research Beam added a report on “Pancreatic Cancer Therapeutics in Major Developed Markets to 2021” Enquiry about report: http://www.researchbeam.com/pancreatic-cancer-therapeutics-in-major-developed-to-2021-strong-late-stage-pipeline-holds-promise-for-increasingly-diverse-landscape-market/enquire-about-report
The report estimates the market size for 2014, along with forecasts until 2021. It also covers disease epidemiology, treatment algorithms, treatment use patterns, in-depth analysis of pipeline molecules, clinical trial failure rates, and analysis of recent deals. It is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis carried out by GBI Research team of industry experts. Enquiry @ http://www.researchbeam.com/psoriasis-therapeutics-in-asia-pacific-to-2021-advent-of-novel-biologics-and-expanding-treatment-pool-to-drive-growth-market/enquire-about-report
Big Market Research has announced a new Report Package "Protein Purification and Isolation Market- Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2020" Get Complete Report at: http://www.bigmarketresearch.com/protein-purification-and-isolation-mnm-market Protein purification involves the process of isolating proteins from the source, based on differences in their physical properties. The objective of a protein purification process is to isolate the largest amount of functional protein with fewest contaminants. The global protein purification and isolation market is expected to grow at a CAGR of around 5% to 6% during the forecast period. Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/280844
A new report on Global Oral Proteins and Peptides Industry 2016 Market Research Report seen on DecisionDatabases.com analyses the complete market. The industry sales & production volumes, industry’s trends are all discussed,explained and analysed.
Multiple Myeloma (MM) is a hematological malignancy characterized by the proliferation of plasma cells in the bone marrow. It is the second-most frequently diagnosed hematological malignancy, with an annual prevalence in the US of about 45,000. The disease is considered incurable, although the past decade has seen significant improvements in therapy, driven by a greater understanding of pathophysiology. Many of the leading drugs in the market were approved over the past 10–15 years, and have improved median survival rates by about 50%. Enquiry @ http://www.researchbeam.com/multiple-myeloma-therapeutics-in-major-developed-to-2021-growth-driven-by-rising-prevalence-continued-success-of-revlimid-and-emerging-supplementary-treatments-market/enquire-about-report
Research projects that the Oral Proteins and Peptides market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025.
Recent study on Protein Kinase C (PKC) Inhibitors API market now added by a leading business intelligence provider to MarketReportsOnline.com database.
The Global Dairy Protein Market size is expected to reach $13.4 billion by 2025, rising at a market growth of 5.9% CAGR during the forecast period. Free Valuable Insights: https://www.kbvresearch.com/dairy-protein-market/
Complete report on Thalassemia market spread across 45 pages providing 4 company profiles and 4 tables and 28 charts is now available at http://www.marketreportsonline.com/478060.html.
The Cardiovascular Disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia, which accelerate the development of atherosclerotic plaque build up within blood vessels. For more information on the research report, refer to below link:- https://www.kenresearch.com/healthcare/pharmaceuticals/global-cardiovascular-disease-drugs-market-to-2023/142623-91.html